目的采用固体分散技术提高齐酞酸钠口服制剂的溶出速度和稳定性。
醋甲唑胺和乙酰唑胺均可降低眼压，两者效果相当，且眼压没有明显波动。
目的观察不同种类的穿透促进剂对乙酰唑胺滴眼液的眼内通透性作用。
1·Other treatments include intravenous acetazolamide or mannitol, anterior chamber paracentesis, and trabeculectomy.
其它治疗方法包括静脉滴注乙酰唑胺或甘露醇，前房穿刺，和小梁切除术。
2·Quantitative blood flow measures showed no difference in the magnitude of regional cerebral blood flow responses pretreatment and posttreatment to either memory tasks or acetazolamide injection.
血流定量检测显示：无论记忆任务还是乙酰唑胺注射，治疗前后局部脑血流的强度无显著差异。
3·MethodsUsing the solid phase extraction technique, acetazolamide was extracted from the aqueous humor, and detected by RP HPLC.
方法乙酰唑胺房水样品经固相萃取后，进行RP - HPLC检测。
4·Objective: To explore the effects of acetazolamide on the ultrastructure of stria vascularis and endolymphatic sac.
目的：探讨乙酰唑胺对血管纹和内淋巴囊上皮细胞超微结构的影响。
5·CONCLUSION Acetazolamide decreased the osmotic water permeability induced by AQP1 and inhibited the water transporting function of AQP1 in a dose dependent manner.
结论乙酰唑胺剂量依赖性地降低AQP1介导的渗透水通透性，抑制AQP1转运水的功能。